BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16093313)

  • 21. Smad6 promotes neuronal differentiation in the intermediate zone of the dorsal neural tube by inhibition of the Wnt/beta-catenin pathway.
    Xie Z; Chen Y; Li Z; Bai G; Zhu Y; Yan R; Tan F; Chen YG; Guillemot F; Li L; Jing N
    Proc Natl Acad Sci U S A; 2011 Jul; 108(29):12119-24. PubMed ID: 21730158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgens up-regulate transcription of the Notch inhibitor Numb in C2C12 myoblasts via Wnt/β-catenin signaling to T cell factor elements in the Numb promoter.
    Liu XH; Wu Y; Yao S; Levine AC; Kirschenbaum A; Collier L; Bauman WA; Cardozo CP
    J Biol Chem; 2013 Jun; 288(25):17990-8. PubMed ID: 23649620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presenilin-1 interacts with plakoglobin and enhances plakoglobin-Tcf-4 association. Implications for the regulation of beta-catenin/Tcf-4-dependent transcription.
    Raurell I; Castaño J; Francí C; García de Herreros A; Duñach M
    J Biol Chem; 2006 Jan; 281(3):1401-11. PubMed ID: 16306047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TIS7 regulation of the beta-catenin/Tcf-4 target gene osteopontin (OPN) is histone deacetylase-dependent.
    Vietor I; Kurzbauer R; Brosch G; Huber LA
    J Biol Chem; 2005 Dec; 280(48):39795-801. PubMed ID: 16204248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating Wnt signaling: a chemogenomic safari.
    McMillan M; Kahn M
    Drug Discov Today; 2005 Nov; 10(21):1467-74. PubMed ID: 16243267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ku70 and poly(ADP-ribose) polymerase-1 competitively regulate beta-catenin and T-cell factor-4-mediated gene transactivation: possible linkage of DNA damage recognition and Wnt signaling.
    Idogawa M; Masutani M; Shitashige M; Honda K; Tokino T; Shinomura Y; Imai K; Hirohashi S; Yamada T
    Cancer Res; 2007 Feb; 67(3):911-8. PubMed ID: 17283121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis.
    Hao S; He W; Li Y; Ding H; Hou Y; Nie J; Hou FF; Kahn M; Liu Y
    J Am Soc Nephrol; 2011 Sep; 22(9):1642-53. PubMed ID: 21816937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of inhibition of CBP-coactivated β-catenin-mediated Wnt signalling in uremic rats with vascular calcifications.
    Gravesen E; Nordholm A; Mace M; Morevati M; Høgdall E; Nielsen C; Kjær A; Olgaard K; Lewin E
    PLoS One; 2018; 13(8):e0201936. PubMed ID: 30075015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells.
    Zhao Y; Masiello D; McMillian M; Nguyen C; Wu Y; Melendez E; Smbatyan G; Kida A; He Y; Teo JL; Kahn M
    Oncogene; 2016 Jul; 35(28):3705-17. PubMed ID: 26657156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CBP/p300 are bimodal regulators of Wnt signaling.
    Li J; Sutter C; Parker DS; Blauwkamp T; Fang M; Cadigan KM
    EMBO J; 2007 May; 26(9):2284-94. PubMed ID: 17410209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gamma-secretase-dependent and -independent effects of presenilin1 on beta-catenin.Tcf-4 transcriptional activity.
    Raurell I; Codina M; Casagolda D; Del Valle B; Baulida J; de Herreros AG; Duñach M
    PLoS One; 2008; 3(12):e4080. PubMed ID: 19114997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?
    Mulholland DJ; Dedhar S; Coetzee GA; Nelson CC
    Endocr Rev; 2005 Dec; 26(7):898-915. PubMed ID: 16126938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12.
    Akcora BÖ; Storm G; Bansal R
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):804-818. PubMed ID: 29217140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of a novel small-molecule inhibitor of β-catenin signaling.
    Delgado ER; Yang J; So J; Leimgruber S; Kahn M; Ishitani T; Shin D; Mustata Wilson G; Monga SP
    Am J Pathol; 2014 Jul; 184(7):2111-22. PubMed ID: 24819961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt-promoted Isl1 expression through a novel TCF/LEF1 binding site and H3K9 acetylation in early stages of cardiomyocyte differentiation of P19CL6 cells.
    Lu H; Li Y; Wang Y; Liu Y; Wang W; Jia Z; Chen P; Ma K; Zhou C
    Mol Cell Biochem; 2014 Jun; 391(1-2):183-92. PubMed ID: 24610003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presenilin 1 mediates retinoic acid-induced differentiation of SH-SY5Y cells through facilitation of Wnt signaling.
    Uemura K; Kitagawa N; Kohno R; Kuzuya A; Kageyama T; Shibasaki H; Shimohama S
    J Neurosci Res; 2003 Jul; 73(2):166-75. PubMed ID: 12836159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Regulatory Network Involving β-Catenin, e-Cadherin, PI3k/Akt, and Slug Balances Self-Renewal and Differentiation of Human Pluripotent Stem Cells In Response to Wnt Signaling.
    Huang TS; Li L; Moalim-Nour L; Jia D; Bai J; Yao Z; Bennett SA; Figeys D; Wang L
    Stem Cells; 2015 May; 33(5):1419-33. PubMed ID: 25538040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors.
    Singh R; Artaza JN; Taylor WE; Braga M; Yuan X; Gonzalez-Cadavid NF; Bhasin S
    Endocrinology; 2006 Jan; 147(1):141-54. PubMed ID: 16210377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.
    Kartha VK; Alamoud KA; Sadykov K; Nguyen BC; Laroche F; Feng H; Lee J; Pai SI; Varelas X; Egloff AM; Snyder-Cappione JE; Belkina AC; Bais MV; Monti S; Kukuruzinska MA
    Genome Med; 2018 Jul; 10(1):54. PubMed ID: 30029671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem-like phenotype through modulation of the PI3K/Akt/β-catenin/CBP pathway.
    He K; Xu T; Xu Y; Ring A; Kahn M; Goldkorn A
    Int J Cancer; 2014 Jan; 134(1):43-54. PubMed ID: 23784558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.